Recent news out of Paris indicates a much anticipated Respiratory Syncytial Virus (RSV) prevention treatment for children may soon gain European regulator approval. Moreover, this innovative vaccine-like RSV treatment could become a financial blockbuster.
Will Europe Lead RSV Prevention
Recent news out of Paris indicates a much anticipated Respiratory Syncytial Virus (RSV) prevention treatment for children may soon gain European regulator approval. Moreover, this innovative vaccine-like RSV treatment could become a financial blockbuster.